Neonatal abstinence syndrome after intrauterine opioid exposure: Standards, cost-effectiveness of treatment and maternal rights
Wedi'i Gadw mewn:
Brandt, L., et al., Neonatal abstinence syndrome after intrauterine opioid exposure: Standards, cost-effectiveness of treatment and maternal rights. Heroin Addiction & Related Clinical Problems, vol. 17, n. 2-3, 2015, p. 35-44.
Ref.
513522
Lleoliad:
SIIS Archivo (R.1828)
Palabras clave:
Drogodependencias, Madre, Recién nacido, Síndrome de abstinencia, Embarazo, Programas de mantenimiento, Análisis coste eficacia, Tratamiento, Metadona, Buprenorfina, Derechos, Atención materno infantil, Evaluación de servicios
Drogodependencias, Madre, Recién nacido, Síndrome de abstinencia, Embarazo, Programas de mantenimiento, Análisis coste eficacia, Tratamiento, Metadona, Buprenorfina, Derechos, Atención materno infantil, Evaluación de servicios
Eitemau Tebyg: Neonatal abstinence syndrome after intrauterine opioid exposure: Standards, cost-effectiveness of treatment and maternal rights
- NEONATAL ABSTINENCE SYNDROME AFTER MATERNAL METHADONE TREATMENT
- NEONATAL ABSTINENCE SYNDROME DUE TO CODEINE
- REVISED DOSE SCHEMA OF SUBLINGUAL BUPRENORPHINE IN THE TREATMENT OF THE NEONATAL OPIOID ABSTINENCE SYNDROME
- Observational study in an outpatient clinic specializing in treating opioid- dependent pregnant women: neonatal abstinence syndrome in infants exposed to methadone-, buprenorphine- and slow-release oral morphine
- OPIOID MAINTENACE TREATMENT DURING PREGNANCY: OCCURRENCE AND SEVERITY OF NEONATAL ABSTINENCE SYNDROME
- MANAGEMENT OF NEONATAL ABSTINENCE SYNDROME IN NEONATES BORN TO OPIOID MAINTAINED WOMEN